FPT Retail (FRT) Q2 Profit Surges 187%, Launches Medical Testing
This Aveluro analysis covers FRT on HOSE in the Retail sector. The classified event type is earnings beat, with positive sentiment and a deterministic market-impact score of 6.9/10. Aveluro classifies this story as a positive catalyst in the stock's news coverage. Source coverage came from CafeF - Doanh nghiệp, classified as a primary/top-tier source.
Key Facts
Caveat: Not investment advice. · How Aveluro computed this: Aveluro combines extracted event facts, source credibility, ticker context, and market data. Scores are deterministic research signals, not recommendations.
Overview
FPT Retail (HoSE: FRT) reported a record Q2 net profit of VND 451 billion, up 187% year-on-year, and launched Long Chau medical testing services in early August. The news drove FRT shares up nearly 40% in two weeks, reflecting strong investor sentiment toward the company’s expansion into healthcare services.
Key Facts
- Q2 2026 net profit reached VND 451 billion, up 187% YoY.
- Q2 revenue reached VND 15,626 billion, up 37% YoY.
- H1 2026 consolidated revenue reached VND 30,743 billion, up 33% YoY, completing 52% of the annual plan.
- H1 2026 pre-tax profit reached VND 1,038 billion, completing 67% of the annual plan.
- Long Chau pharmacy chain revenue in H1 reached VND 21,448 billion, up 33% YoY, with average revenue of VND 1.3 billion per pharmacy per month.
- Long Chau network reached 2,639 pharmacies by end-June 2026, and 236 vaccination centers.
- Long Chau launched medical testing services in early August 2026, offering routine and cancer screening tests.
What Happened
FPT Retail announced on its Long Chau website in early August the official launch of Long Chau Testing, a medical testing system applying international-standard technology. This marks the third pillar of Long Chau’s healthcare ecosystem, following its pharmacy chain and vaccination centers.
In its Q2 2026 financial report, the company attributed profit growth to strong contributions from both its retail and pharmacy segments, with Long Chau as the primary driver. The company’s explanation highlights the continued expansion and operational efficiency of the pharmacy chain.
Market Context
FRT shares on HOSE surged from VND 107,700 on July 28 to VND 148,000 on August 12, a 37% gain in just over two weeks. The rally aligns with the earnings beat and the new service launch, reflecting investor optimism about FPT Retail’s pivot toward higher-margin healthcare services. The broader Vietnamese retail sector has seen increased interest in healthcare-related plays.
Strategic Significance
Long Chau’s move into medical testing positions FPT Retail to capture a larger share of Vietnam’s growing preventive healthcare market. By leveraging its extensive pharmacy network and customer base, the company can cross-sell testing services, potentially increasing customer loyalty and revenue per store. This diversification beyond traditional pharmacy retail could support long-term earnings growth and reduce reliance on drug sales alone.
What to Watch
- Monthly pharmacy revenue per store trends to see if testing services lift average revenue.
- Expansion pace of Long Chau testing centers and their contribution to overall revenue.
- Q3 2026 earnings release to confirm sustained profit growth.
- Regulatory developments in Vietnam’s medical testing sector that could affect service rollout.
- Competitive response from other pharmacy chains or diagnostic labs.